The Effect of Exercise on Myokine Production in Aging Persons
NCT ID: NCT05571709
Last Updated: 2023-03-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
20 participants
INTERVENTIONAL
2022-09-15
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Mechanisms of Anabolic Resistance in Older Humans
NCT06617195
The Effects of Age on Muscle Endurance During Resistance Exercise With and Without Blood Flow Restriction
NCT07090603
The Effects of Low- and High-intensity Resistance Exercise on Force-velocity Characteristics in Older Adults
NCT01707017
The Effects of Exercise Intervention on Skeletal Muscle and Other Organs in Aged Population and the Discovery of Associated Circulating Biomarkers
NCT06660706
Exercise Frequency During Endurance Training: Cardiorespiratory, Hematological, and Muscle Oxidative Adaptations
NCT05908578
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Aged individuals who perform exercise training
Aged individuals will perform an acute bout of resistance trainig (30 minutes). This training is focused on the lower limbs.
Exercise training
Resistance training of the lower limbs
Questionnaire
Physical activity questionnaire
Percutaneous muscle biopsy
Muscle biopsy of the vastus lateralis (m. quadriceps)
Blood sample
Venous blood sample
Aged individuals who stay sedentary
Aged individuals will remain seated for 30 minutes.
Questionnaire
Physical activity questionnaire
Percutaneous muscle biopsy
Muscle biopsy of the vastus lateralis (m. quadriceps)
Blood sample
Venous blood sample
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Exercise training
Resistance training of the lower limbs
Questionnaire
Physical activity questionnaire
Percutaneous muscle biopsy
Muscle biopsy of the vastus lateralis (m. quadriceps)
Blood sample
Venous blood sample
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Infection \< 2 weeks ago
* Received a vaccine \< 2 weeks ago
* Allergy to Lidocain
* Immune deficiency
* Presence of a tumour or in treatment
* Usage of anti-coagulant medication
* Presence of following conditions:
* Haemophilia
* Auto-immune disease
* Cardiovascular disease
* Musculoskeletal diseases which refrains the patient from exercising
65 Years
85 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hasselt University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Niels Hellings
Professor Doctor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Chiel Hex, MD.
Role: PRINCIPAL_INVESTIGATOR
University of Hasselt
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hasselt University
Diepenbeek, Limburg, Belgium
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
B1152022000006
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.